GEN Exclusives

More »

GEN News Highlights

More »
Feb 11, 2010

Qiagen to Distribute Celera’s ResPlex II Multiplex Assay for Respiratory Pathogens

  • Qiagen negotiated exclusive, worldwide distribution rights to Celera’s next-generation ResPlex II multiplex assay for the detection of respiratory pathogens. The new assay detects 19 different pathogens and is designed for use with the Luminex LiquiChip 100 and 200 instrument platforms, for which Qiagen is also a partner. The test has yet to be submitted for regulatory approval in the U.S. and Europe.


Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Mindclones and Immortality

Is the idea of making a software copy of a human mind something in the realm of reality or science fiction?